LINE1 Derepression in Aged Wild-Type and SIRT6-Deficient Mice Drives Inflammation

LINE1在老年野生型和SIRT6缺陷型小鼠中的去抑制驱动炎症

阅读:5
作者:Matthew Simon ,Michael Van Meter ,Julia Ablaeva ,Zhonghe Ke ,Raul S Gonzalez ,Taketo Taguchi ,Marco De Cecco ,Katerina I Leonova ,Valeria Kogan ,Stephen L Helfand ,Nicola Neretti ,Asael Roichman ,Haim Y Cohen ,Margarita V Meer ,Vadim N Gladyshev ,Marina P Antoch ,Andrei V Gudkov ,John M Sedivy ,Andrei Seluanov ,Vera Gorbunova

Abstract

Mice deficient for SIRT6 exhibit a severely shortened lifespan, growth retardation, and highly elevated LINE1 (L1) activity. Here we report that SIRT6-deficient cells and tissues accumulate abundant cytoplasmic L1 cDNA, which triggers strong type I interferon response via activation of cGAS. Remarkably, nucleoside reverse-transcriptase inhibitors (NRTIs), which inhibit L1 retrotransposition, significantly improved health and lifespan of SIRT6 knockout mice and completely rescued type I interferon response. In tissue culture, inhibition of L1 with siRNA or NRTIs abrogated type I interferon response, in addition to a significant reduction of DNA damage markers. These results indicate that L1 activation contributes to the pathologies of SIRT6 knockout mice. Similarly, L1 transcription, cytoplasmic cDNA copy number, and type I interferons were elevated in the wild-type aged mice. As sterile inflammation is a hallmark of aging, we propose that modulating L1 activity may be an important strategy for attenuating age-related pathologies.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。